Академический Документы
Профессиональный Документы
Культура Документы
administration of drugs
via enteral feeding tubes
Enteral Parenteral Nutrition
Support Committee
Midlands Regional Hospital
at Tullamore (2009)
Purpose
This guideline aims to improve pharmaceutical care of
patients receiving nutrition through enteral feeding tubes
(nasogastric, nasoduodenal, nasojejunal, gastrostomy/PEG,
jejunostomy) by ensuring that drugs are administered in the
safest and most effective manner.
Capsule:
Modified release:
Incompatibility:
Scope
This guideline applies to all nursing and medical staff caring
for patients who are to receive drugs via enteral feeding
tubes. It also applies to pharmacists and dieticians who may
be advising the above staff.
Cautionary Notice
PLEASE NOTE THAT THE CORRECT ADMINISTRATION
OF DRUGS VIA ENTERAL FEEDING TUBES MAY
INCLUDE A SIGNIFICANT VOLUME OF WATER. IF
PATIENTS RECEIVING ENTERAL FEEDING ARE FLUID
RESTRICTED OR ARE AT RISK OF COMPLICATIONS
FROM EXCESSIVE FLUID INTAKE PLEASE REFER TO
THE MEDICAL/SURGICAL TEAM BEFORE FOLLOWING
THE PROCEDURES OUTLINED IN THIS GUIDE.
Disclaimer
The information in this book is intended as a guide to the administration of
medication via enteral feeding tubes. Such administration is usually outside
the product licence. No liability is accepted for any injury, loss or damage,
however caused.
Guideline
For patients on fluid restriction please see
the cautionary notice before proceeding.
Choice of Drug
The medical team should review the drug therapy of every
patient who is commencing on enteral feeding. Drugs, which are
considered not to be essential in the short-term, can be withheld if
appropriate.
Choice of Route of Administration
An alternative route to the enteral feeding route should be used
to give the drug if appropriate. This may require a change to a
different drug.
Choice of Drug Formulation
(a) Drugs that are in a Liquid Form:
If available, these are preferable for administration via enteral tubes.
These include syrups, linctus, elixirs, suspensions, solutions and
dispersible, effervescent or soluble tablets.
(b) Drugs that are in a Solid Form:
(1) Uncoated Tablets:
These may be crushed with care at the bedside and administered
immediately (see section on Precautions Before and After
Administering below). Do not mix powders. Always wear gloves.
(2) Coated Tablets:
Do not crush enteric coated (EC), sugar coated (hard shiny
appearance) or modified release (MR) tablets. Certain drugs, listed
in Table 1 of this guideline require special attention. Consult a
pharmacist for advice and advise the prescribing team.
(3) Capsules:
Hard gelatin capsules can be opened and the contents given via
NG tube, provided that they are not modified release capsules (see
section on Precautions Before and After Administering below). Soft
gelatin capsules can be punctured with a wide bore needle and the
liquid withdrawn and given by syringe into the enteral tube.
(4) Cytotoxic drugs and hormones should never be crushed
Drug-Feed Interactions
As a general rule of thumb, drugs which should be given on an
empty stomach should not be given at the same time as enteral
feed. Feed should be stopped for 1-2 hours before and 1-2 hours
after such drugs are administered. Certain drugs, listed in Table 3 of
this guideline require special attention.
Precautions Before and After Administering
Each drug should be dissolved or dispersed in 20-30mls of
sterile water.
To prevent blockage of the enteral feeding tube:
20-30mls of sterile water (or more if recommended by
the dietitian on the enteral feeding regime) should be
administered before any drugs are given.
5-10mls should be given between each drug.
20-30mls of sterile water (or more if recommended by
dietitian on enteral feeding regime) should be given after
administration of the drugs.
Requests to pharmacy for clog zappers may indicate the need
for a member of the pharmacy team to review the patients
medications.
This fluid should be taken into account in any fluid balance
calculations for patients on restricted fluid intake or at risk of
complications from excessive fluid intake. Consult the medical or
surgical team.
Is the drug
essential?
Yes
Can an alternative
route be used?
No
No
Can an alternative
formulation
be used?
Do Not Crush
Enteric coated (EC)
Modified release
(MR)
Buccal
Sublingual
Chewable
Cytotoxic
Pancreatic
hormones
Antibiotics
Prostaglandin
analogues
Technique:
Yes
Yes
Buccal
Sublingual
Transdermal
Topical
Parenteral
Nebulised/Inhaled
Rectal
Vaginal
No
Can an alternative
drug be used?
No
Yes
Formulation
Drug feed interaction
Type of feeding tube
Site of feeding tube
Site of drug absorption
Manipulate the
solid oral
dosage form
Withdraw contents
from soft gelatin
capsules
Specific drugs
and guidelines for
administration:
Please Note:
Information listed
in Table 1 is for
guidance only and
may be subject to
review. Always check
the most recent
BNF or SPC for a
product. This list is not
exhaustive.
ACICLOVIR (Zovirax)
AMINOPHYLLINE
(Phyllocontin continus)
AMIODARONE
(Cordarone)
ANTACIDS
(Gaviscon, Maalox)
ASPIRIN (Nu-Seals,
Disprin)
CEFUROXIME (Zinnat)
CHLORPHENIRAMINE
(Piriton)
CHLORPROMAZINE
(Clonactil)
CITALOPRAM (Cipramil)
CLARITHROMYCIN
(Klacid)
ASPIRIN + DIPYRIDAMOLE Open capsule, discard mini aspirin tablet & give
micro-granules via tube without crushing them.
(Asasantan Retard)
The aspirin may be replaced an additional
75mg dispersible tablet once daily.
BACLOFEN (Lioresal)
BISOCODYL (Dulco-Lax )
BISPHOSPHONATES:
e.g. Alendronate Na+
(Fosamax)
Risedronate Na+
(Actonel)
DILTIAZEM
(Tildiem, Dilzem,
Adizem)
DOMPERIDONE
(Motilium, Domerid)
DOXAZOSIN
(Cardura, Cardura XL)
Doxycycline
ERYTHROMYCIN
(Erymax, Erythroped)
FERROUS SULPHATE
(Ferrograd)
FERROUS FUMARATE
(Galfer)
FLUCLOXACILLIN
(Floxapen)
FLUOXETINE (Prozac)
FOLIC ACID
FUROSEMIDE
(Lasix, Fruside)
GABAPENTIN (Neurontin)
GLICLAZIDE
(Diamicron and
Diamicron MR)
HYOSCINE BUTYL
BROMIDE (Buscopan)
ISOSORBIDE
MONONITRATE
(Elantan, Imdur)
LACTULOSE (Duphalac)
LANSOPRAZOLE (Zoton )
LEVO-THYROXINE
(Eltroxin)
LITHIUM
(Camcolit, Priadel)
LOPERAMIDE (Imodium)
METOCLOPRAMIDE
(Maxolon)
OXYBUTININ
(Cystrin, Ditropan)
PANTOPRAZOLE
(Protium)
MORPHINE (Sevredol)
PARACETAMOL
(Panadol, Maxilief)
NIFEDIPINE
(Adalat, Adalat LA,
Adalat Retard)
PAROXETINE (Seroxat)
PHENOXYMETHYL
PENICILLIN/PENICILLIN V
(Calvepen, Kopen)
PHENYTOIN (Epanutin)
MORPHINE
(MST continus)
crushed.
OLANZAPINE (Zyprexa)
OMEPRAZOLE (Losec)
POTASSIUM CHLORIDE
[KCL] (Slow-K)
SODIUM VALPROATE
(Epilim)
PREDNISOLONE
(Prednesol)
SOTALOL (Sotacor)
PREGABALIN (Lyrica)
Strontium ranelate
(Protelos)
PROCHLORPERAZINE
(Stemetil)
SUCRALFATE (Antepsin)
PROPRANOLOL
(Inderal LA)
QUINOLONE
ANTIBIOTICS:
CIPROFLOXACIN
(Ciproxin, Truoxin)
OFLOXACIN (Tarivid)
LEVOFLOXACIN (Tavanic)
RABEPRAZOLE (Pariet)
RANITIDINE (Zantac )
RIFAMPICIN (Rifadin)
SALBUTAMOL (Ventolin)
SENNA (Senokot)
TEMAZEPAM (Nortem)
THEOPHYLLINE (Nuelin,
Slo-Phyllin, Uniphyllin)
VENLAFAXINE
(Efexor, Efexor XL)
WARFARIN
Brand names
DOXAZOSIN
Cardura XL
GLICLAZIDE
Diamicron MR
HYDROCORTISONE
Corlan pellets
HYOSCINE BUTYLBROMIDE
Buscopan
ISOSORBIDE MONONITRATE
Elantan LA
LANSOPRAZOLE
Zoton
MISOPROSTOL
Arthrotec
Cytotec
MORPHINE
MST Continus
NIFEDIPINE
Adalat LA
Adalat Retard
Drug
Brand names
OXYBUTININ
Lyrinel XL
AMINOPHYLLINE
Phyllocontin Continus
SODIUM VALPROATE
ASPIRIN
Caprin
Nu-Seals
THEOPHYLLINE
ASPIRIN + DIPYRIDAMOLE
Asasantan Retard
Neulin SA
Slo-Phylin
Uniphyllin Continus
BISOCODYL
Dulco-Lax
VENLAFAXINE
Efexor XL
BISPHOSPHONATES:
e.g. Alendronate Na+
Risedronate Na+
Fosamax
Actonel
DILTIAZEM
Adizem XL
Adizem SR
Dilzem XL
Adizem SR
Tildiem LA
Tildiem Retard
Drug
Brand names
Antibiotic
Ciprofloxacin
Ciproxin
Truoxin
Doxycycline
Mycin
Vibramycin
Flucloxacillin
Floxapen
Isoniazid
N/A
Levofloxacin
Tavanic
Ofloxacin
Tarivid
Phenoxymethyl
penicillin/Penicillin V
Calvepen
Rifampicin
Rifadin
Phenytoin
Epanutin
Carbamazepine
Tegretol
Anatcid
Gaviscon
Maalox
Bronchodilator
Theophylline
Nuelin
Slo-Phyllin
Uniphyllin
Strontium Ranelate
Protelos
Feed should be stopped for 1-2 hours before and 1-2 hours after
administration of the following drugs. See Table 1 of this guideline
for more detailed information on administration of these drugs.
Anti-epileptic
References
Key Sources: